An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Nextstellis

Chemical Namedrospirenone and estetrol
Dosage FormTablet (oral; 24 pink active tablets each containing drospirenone 3 mg and estetrol 14.2 mg, and 4 white inert tablets)
Drug ClassHormones
SystemFemale reproductive
CompanyMayne Pharma
Approval Year2021

Indication

  • Indicated for use by females of reproductive potential to prevent pregnancy.
Last updated on 4/30/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Nextstellis (drospirenone and estetrol) Prescribing Information2021Mayne Pharma, Greenville, NC
Document TitleYearSource
A multicenter, open-label, single-arm study to evaluate the contraceptive efficacy and safety of a combined oral contraceptive containing 15 mg estetrol and 3 mg drospirenone.2020Estetra